Search Results 241-250 of 14247 for Phosphate de Potassium

  1. Medical Research & Education - Mayo Clinic News Network

    Cancer. Tumor Size is Defining Factor to Response from Promising Melanoma Drug · Cancer. Pesquisadores da Mayo Clinic dizem que molécula ligada a câncer de ...

  2. Publications - Zach J. Fleissner, D.O. - Mayo Clinic

    Assis MLM, Bojaxhi E, Abode-Iyamah KO, Patterson JS, White KE, Gruenbaum SE, Rabai F, De Ruyter ML, Riutort KT, Fleissner ZJ, Pirris SM, Barbosa M, Gruenbaum BF ...

  3. Kidney transplant - Mayo Clinic

    Find out about the different types of kidney transplants — surgeries that are done to treat kidney failure.

  4. Medical Research & Education - Mayo Clinic News Network

    ... de tratamento. Paul Scotti. June 5, 2014. Cancer. Tamanho do tumor é fator ... June 5, 2014. Cancer. Tamanho do tumor é fator determinante para resposta a ...

  5. Medical Research & Education - Mayo Clinic News Network

    Latest stories. Health & Wellness. Forma atípica de doença de Alzheimer pode estar presente em um grande número de pacientes, diz a Mayo Clinic. May 12, 2014.

  6. Medical Research & Education - Mayo Clinic News Network

    Forma atípica de doença de Alzheimer pode estar presente em um grande número de pacientes, diz a Mayo Clinic. May 12, 2014. Minnesota. Mayo Clinic launches ...

  7. Cardiovascular Medicine - Clinical trials

    ... potassium voltage-gated channel subfamily Q member 1 (KCNQ1), potassium voltage-gated channel subfamily H member 2 (KCNH2), or sodium voltage-gated ...

  8. Publications - Joaquin J. Garcia, M.D. - Mayo Clinic

    De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a ...

  9. Erectile dysfunction - Doctors and departments - Mayo Clinic

    Understand what can cause the inability to get and keep an erection firm enough for sex and the possible treatment options.

  10. Publications - Bassam G. Abu Jawdeh, M.D. - Mayo Clinic

    Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report.